Menu
Back to Journals » Vascular Health and Risk Management » Volume 5 » default
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1489)
- Volume 19, 2023 (79)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 5, 2009
Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program
R Michael Kirchner, J Dawn Abbott
Vascular Health and Risk Management 2009, 5:1089-1097
Published Date: 16 December 2009
Nitric oxide and coronary vascular endothelium adaptations in hypertension
Andrew S Levy, Justin CS Chung, Jeffrey T Kroetsch, et al
Vascular Health and Risk Management 2009, 5:1075-1087
Published Date: 16 December 2009
Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
Jean-Philippe Baguet, Marie Nadra, Gilles Barone-Rochette, et al
Vascular Health and Risk Management 2009, 5:1063-1073
Published Date: 11 December 2009
Persistent high fever and systemic inflammation induced by percutaneous coronary intervention-related periaortitis
Takamori Kakino, Tomohiro Nakayama, Hideo Yamamoto
Vascular Health and Risk Management 2009, 5:1059-1062
Published Date: 8 December 2009
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Thomas Mengden, Sakir Uen, Peter Bramlage
Vascular Health and Risk Management 2009, 5:1043-1058
Published Date: 30 November 2009
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Venkata Narla, Michael J Blaha, Roger S Blumenthal, et al
Vascular Health and Risk Management 2009, 5:1033-1042
Published Date: 27 November 2009
Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence
Daniel J Moore, Justin M Gregory, Yaa A Kumah-Crystal, et al
Vascular Health and Risk Management 2009, 5:1015-1031
Published Date: 18 November 2009
Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India
Krishna K Sharma, Rajeev Gupta, Aachu Agrawal, et al
Vascular Health and Risk Management 2009, 5:1007-1014
Published Date: 20 November 2009
Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo
C Makena Hightower, Joyce D Hightower, Beatriz Y Salazar Vázquez, et al
Vascular Health and Risk Management 2009, 5:1001-1005
Published Date: 17 November 2009
Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice
Roland E Schmieder, Markus Schwertfeger, Peter Bramlage
Vascular Health and Risk Management 2009, 5:991-1000
Published Date: 12 November 2009
Vascular health in children and adolescents: effects of obesity and diabetes
Kevin R Short, Piers R Blackett, Andrew W Gardner, et al
Vascular Health and Risk Management 2009, 5:973-990
Published Date: 10 November 2009
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
Rakesh K Sharma, Hanumanth K Reddy, Vibhuti N Singh, et al
Vascular Health and Risk Management 2009, 5:965-972
Published Date: 9 November 2009
The treatment of diabetic foot infections: focus on ertapenem
Michael Edmonds
Vascular Health and Risk Management 2009, 5:949-963
Published Date: 6 November 2009
Comparative assessment of angiotensin receptor blockers in different clinical settings
Paolo Verdecchia, Fabio Angeli, Salvatore Repaci, et al
Vascular Health and Risk Management 2009, 5:939-948
Published Date: 6 November 2009
Erratum
Zeina AR, Slobodin G, Naschitz JE et al.
Vascular Health and Risk Management 2009, 5:937-938
Published Date: 3 November 2009
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Yasushi Saito
Vascular Health and Risk Management 2009, 5:921-936
Published Date: 3 November 2009
Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea
Sanja Jelic, David J Lederer, Tessa Adams, et al.
Vascular Health and Risk Management 2009, 5:909-920
Published Date: 3 November 2009
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Klaus G Parhofer
Vascular Health and Risk Management 2009, 5:901-908
Published Date: 3 November 2009
Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
Nikolaos Östlund Papadogeorgos, Mattias Bengtsson, Majid Kalani
Vascular Health and Risk Management 2009, 5:893-899
Published Date: 28 October 2009
Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control
Dion Zappe, Cheraz Cherif Papst, Philippe Ferber, et al.
Vascular Health and Risk Management 2009, 5:883-892
Published Date: 22 October 2009
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Nicholas B Norgard, Mazen Abu-Fadel
Vascular Health and Risk Management 2009, 5:873-882
Published Date: 21 October 2009
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies
Matthias Meier, Michael Hummel
Vascular Health and Risk Management 2009, 5:859-871
Published Date: 19 October 2009
Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects
Lars Maegdefessel, Axel Schlitt, Susanna Pippig, et al
Vascular Health and Risk Management 2009, 5:849-857
Published Date: 9 October 2009
Treatment of congenital fibrinogen deficiency: overview and recent findings
Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al
Vascular Health and Risk Management 2009, 5:843-848
Published Date: 5 October 2009
Ankle Brachial Pressure Index (ABPI): An update for practitioners
Mo Al-Qaisi, David M Nott, David H King, et al
Vascular Health and Risk Management 2009, 5:833-841
Published Date: 30 September 2009
Update on the clinical use of the low-molecular-weight heparin, parnaparin
Giuseppe Camporese, Enrico Bernardi, Franco Noventa
Vascular Health and Risk Management 2009, 5:819-831
Published Date: 25 September 2009
Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice
Cláudia Maria Vilas Freire, Antonio Luiz Pinho Ribeiro, Felipe Batista Lima Barbosa, et al
Vascular Health and Risk Management 2009, 5:811-817
Published Date: 24 September 2009
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy
Jeetesh V Patel, Inessa Tracey, Elizabeth A Hughes, et al
Vascular Health and Risk Management 2009, 5:801-810
Published Date: 21 September 2009
Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
Rakesh K Sharma, Vibhuti N Singh, Hanumanth K Reddy
Vascular Health and Risk Management 2009, 5:793-799
Published Date: 21 September 2009
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
Gerald V Naccarelli, Frank Peacock
Vascular Health and Risk Management 2009, 5:783-791
Published Date: 11 September 2009
Protein C preserves microcirculation in a model of neonatal septic shock
Doris Fischer, Marcel F Nold, Claudia A Nold-Petry, et al
Vascular Health and Risk Management 2009, 5:775-781
Published Date: 10 September 2009
Antiatherogenic effects of vitamin E: the search for the Holy Grail
Dimitrios Kirmizis, Dimitrios Chatzidimitriou
Vascular Health and Risk Management 2009, 5:767-774
Published Date: 10 September 2009
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Jesús Millán, Xavier Pintó, Anna Muñoz, et al
Vascular Health and Risk Management 2009, 5:757-765
Published Date: 10 September 2009
HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al
Vascular Health and Risk Management 2009, 5:751-756
Published Date: 8 September 2009
Pattern of heart failure in a Nigerian teaching hospital
Arthur C Onwuchekwa, Godspower E Asekomeh
Vascular Health and Risk Management 2009, 5:745-750
Published Date: 7 September 2009
Metabolic syndrome and cardiovascular disease in South Asians
Danny Eapen, Girish L Kalra, Nadya Merchant, et al
Vascular Health and Risk Management 2009, 5:731-743
Published Date: 3 September 2009
Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
Vivencio Barrios, Carlos Escobar, Alberto Calderon, et al
Vascular Health and Risk Management 2009, 5:723-729
Published Date: 27 August 2009
Cardiovascular disease in patients with chronic kidney disease
Julian Wright, Alastair Hutchison
Vascular Health and Risk Management 2009, 5:713-722
Published Date: 26 August 2009
Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: A pilot study
Ramona S DeJesus, Rajeev Chaudhry, Dorinda J Leutink, et al
Vascular Health and Risk Management 2009, 5:705-711
Published Date: 24 August 2009
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
Andrew D Blann, Chee W Khoo
Vascular Health and Risk Management 2009, 5:693-704
Published Date: 4 September 2009
Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
Shailja V Parikh, Ellen C Keeley
Vascular Health and Risk Management 2009, 5:677-691
Published Date: 19 August 2009
Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: A case control study
Mohammad Shojaie, Morteza Pourahmad, Ahad Eshraghian, et al
Vascular Health and Risk Management 2009, 5:673-676
Published Date: 11 August 2009
RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension
Scott A Barman, Shu Zhu, Richard E White
Vascular Health and Risk Management 2009, 5:663-671
Published Date: 9 August 2009
Validation of reported physical activity for cholesterol control using two different physical activity instruments
Amy Z Fan, Sandra A Ham, Shravani Reddy Muppidi, et al
Vascular Health and Risk Management 2009, 5:649-661
Published Date: 6 August 2009
Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country
Ambarish Pandey, Nivedita Patni, Mansher Singh, et al
Vascular Health and Risk Management 2009, 5:643-648
Published Date: 5 August 2009
Dronedarone for atrial fibrillation: a new therapeutic agent
Pawan D Patel, Rohit Bhuriya, Dipal D Patel, et al
Vascular Health and Risk Management 2009, 5:635-642
Published Date: 5 August 2009
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
R Kreidy, N Irani-Hakime
Vascular Health and Risk Management 2009, 5:627-633
Published Date: 31 July 2009
Should embolectomy be performed in late acute lower extremity arterial occlusions?
Hikmet Iyem, M Nesimi Eren
Vascular Health and Risk Management 2009, 5:621-626
Published Date: 31 July 2009
Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
Christopher J Valerio, John G Coghlan
Vascular Health and Risk Management 2009, 5:607-619
Published Date: 5 August 2009
A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
Ji-Guang Wang
Vascular Health and Risk Management 2009, 5:593-605
Published Date: 23 July 2009
Irbesartan improves arterial compliance more than lisinopril
Khalid Ali, Chakravarthi Rajkumar, Francesco Fantin, Rebekah Schiff, Christopher J Bulpitt
Vascular Health and Risk Management 2009, 5:587-592
Published Date: 13 July 2009
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension
Martin Thoenes, Jan-Christian Reil, Bobby Varkey Khan, Peter Bramlage, et al.
Vascular Health and Risk Management 2009, 5:577-585
Published Date: 13 July 2009
Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers
Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.
Vascular Health and Risk Management 2009, 5:567-575
Published Date: 2 July 2009
Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome
Marco Matteo Ciccone, Stefano Favale, Anish Bhuva, Pietro Scicchitano, et al.
Vascular Health and Risk Management 2009, 5:561-566
Published Date: 25 June 2009
The role of insulin detemir in overweight type 2 diabetes management
Yared N Demssie, Naveed Younis, Handrean Soran
Vascular Health and Risk Management 2009, 5:553-560
Published Date: 29 June 2009
Pleiotropic effects of statins in atrial fibrillation patients: the evidence
Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer Ellahham
Vascular Health and Risk Management 2009, 5:533-551
Published Date: 17 June 2009
Histopathologic changes of the radial artery wall secondary to transradial catheterization
Cezar S Staniloae, Kanika P Mody, Kintur Sanghvi, Catalin Mindrescu, et al.
Vascular Health and Risk Management 2009, 5:527-532
Published Date: 23 June 2009
LETTER: A commentary on “A young man with acute dilated cardiomyopathy associated with methylphenidate”
Ahmad Ghanizadeh
Vascular Health and Risk Management 2009, 5:525-526
Published Date: 5 June 2009
Treatment of pediatric pulmonary hypertension
Amy Hawkins, Robert Tulloh
Vascular Health and Risk Management 2009, 5:509-524
Published Date: 3 June 2009
Reducing morbidity and mortality in high risk patients with statins
Vibhuti Singh, Prakash Deedwania
Vascular Health and Risk Management 2009, 5:495-507
Published Date: 5 June 2009
Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts
Nader Nouri-Majalan, Ehsan Fotouhi Ardakani, Khalil Forouzannia, Hosein Moshtaghian
Vascular Health and Risk Management 2009, 5:489-494
Published Date: 27 May 2009
Hematocrit and mean arterial blood pressure in pre- and postmenopause women
Beatriz Y Salazar Vázquez, Miguel A Salazar Vázquez, Marcos Intaglietta, Ulf de Faire, et al.
Vascular Health and Risk Management 2009, 5:483-488
Published Date: 25 May 2009
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel
Zuzana Motovska, Petr Widimsky
Vascular Health and Risk Management 2009, 5:475-481
Published Date: 21 May 2009
Inhaled iloprost for the control of pulmonary hypertension
Sabine Krug, Armin Sablotzki, Stefan Hammerschmidt, Hubert Wirtz, Hans-Juergen Seyfarth
Vascular Health and Risk Management 2009, 5:465-473
Published Date: 19 May 2009
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Eduardo Pimenta, Suzanne Oparil
Vascular Health and Risk Management 2009, 5:453-463
Published Date: 19 May 2009
The use of sibutramine in the management of obesity and related disorders: An update
Konstantinos Tziomalos, Gerasimos E Krassas, Themistoklis Tzotzas
Vascular Health and Risk Management 2009, 5:441-452
Published Date: 14 May 2009
Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension
Amber Lundy, Nahla Lutfi, Cherylyn Beckey
Vascular Health and Risk Management 2009, 5:429-440
Published Date: 8 May 2009
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia
Vascular Health and Risk Management 2009, 5:411-427
Published Date: 8 May 2009
Safety and efficacy of alteplase in the treatment of acute ischemic stroke
Giuseppe Micieli, Simona Marcheselli, Piera Angela Tosi
Vascular Health and Risk Management 2009, 5:397-409
Published Date: 8 May 2009
Safety and efficacy of rosiglitazone in the elderly diabetic patient
Adie Viljoen, Alan Sinclair
Vascular Health and Risk Management 2009, 5:389-395
Published Date: 30 April 2009
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
Madhuri Devabhaktuni, Sripal Bangalore
Vascular Health and Risk Management 2009, 5:377-387
Published Date: 27 April 2009
Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
Naila Goldenberg, Charles Glueck
Vascular Health and Risk Management 2009, 5:369-376
Published Date: 29 April 2009
Prevention of diabetes in hypertensive patients: Results and implications from the VALUE trial
Ming-Sheng Zhou, Ivonne Hernandez Schulman
Vascular Health and Risk Management 2009, 5:361-368
Published Date: 16 April 2009
Arterial stiffness, hypertension, and rational use of nebivolol
Enrico Agabiti-Rosei, Enzo Porteri, Damiano Rizzoni
Vascular Health and Risk Management 2009, 5:353-360
Published Date: 19 May 2009
Efficacy and safety of rosuvastatin in the management of dyslipidemia
Paolo Rubba, Gennaro Marotta, Marco Gentile
Vascular Health and Risk Management 2009, 5:343-352
Published Date: 7 April 2009
Lipid-soluble cigarette smoking particles induce expression of inflammatory and extracellular-matrix-related genes in rat cerebral arteries
Petter Vikman, Cang-Bao Xu, Lars Edvinsson
Vascular Health and Risk Management 2009, 5:333-341
Published Date: 7 April 2009
Review of inhaled iloprost for the control of pulmonary artery hypertension in children
Cecile Tissot, Maurice Beghetti
Vascular Health and Risk Management 2009, 5:325-331
Published Date: 8 April 2009
Prasugrel for the treatment of patients with acute coronary syndrome
Filippo Marzot, Vittorio Pengo
Vascular Health and Risk Management 2009, 5:321-324
Published Date: 6 April 2009
Association between body mass index and chronic kidney disease: A population-based, cross-sectional study of a Japanese community
Ikuo Nomura, Johji Kato, Kazuo Kitamura
Vascular Health and Risk Management 2009, 5:315-320
Published Date: 1 April 2009
Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
Carlos Ferrario
Vascular Health and Risk Management 2009, 5:301-314
Published Date: 26 March 2009
Prevention of atherosclerosis in patients living with HIV
Ferruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, Brian Gazzard, John L McGregor, Kevin Shotliff, Han Xiao
Vascular Health and Risk Management 2009, 5:287-300
Published Date: 26 March 2009
Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
Arijit Dasgupta, Debabrata Mukherjee
Vascular Health and Risk Management 2009, 5:275-286
Published Date: 19 March 2009
Corrigendum
Dove Medical Press Editorial
Vascular Health and Risk Management 2009, 5:273-274
Published Date: 18 March 2009
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
Jacob George, Allan D Struthers
Vascular Health and Risk Management 2009, 5:265-272
Published Date: 5 March 2009
Candesartan cilexetil in the treatment of chronic heart failure
Jean-Philippe Baguet, Gilles Barone-Rochette, Yannick Neuder
Vascular Health and Risk Management 2009, 5:257-264
Published Date: 4 March 2009
Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction
Giovanni Melandri, Fabio Vagnarelli, Daniela Calabrese, Franco Semprini, Samuele Nanni, Angelo Branzi
Vascular Health and Risk Management 2009, 5:249-256
Published Date: 26 February 2009
Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial nfarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: A pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data
Maria De Vita, Francesco Burzotta, Giuseppe GL Biondi-Zoccai, Thierry Lefevre, Dariusz Dudek, et al
Vascular Health and Risk Management 2009, 5:243-247
Published Date: 26 February 2009
The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man
Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli
Vascular Health and Risk Management 2009, 5:233-242
Published Date: 8 February 2009
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
Steve Fordan, Philip Raskin
Vascular Health and Risk Management 2009, 5:225-231
Published Date: 19 February 2009
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
Peter Bramlage
Vascular Health and Risk Management 2009, 5:213-224
Published Date: 11 February 2009
Potential of liraglutide in the treatment of patients with type 2 diabetes
Carolyn F Deacon
Vascular Health and Risk Management 2009, 5:199-211
Published Date: 2 February 2009
Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis
R J M W Rennenberg, A G H Kessels, L J Schurgers, J M A van Engelshoven, P W de Leeuw, A A Kroon
Vascular Health and Risk Management 2009, 5:185-197
Published Date: 22 January 2009
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study
JP Baguet, R Asmar, P Valensi, S Nisse-Durgeat, JM Mallion
Vascular Health and Risk Management 2009, 5:175-183
Published Date: 21 January 2009
Amlodipine and valsartan as components of a rational and effective fixed-dose combination
Bernard Waeber, Luis M Ruilope
Vascular Health and Risk Management 2009, 5:165-174
Published Date: 27 March 2009
The management of gestational diabetes
N Wah Cheung
Vascular Health and Risk Management 2009, 5:153-164
Published Date: 15 January 2009
Redefining the role of thiazolidinediones in the management of type 2 diabetes
Anthony H Barnett
Vascular Health and Risk Management 2009, 5:141-151
Published Date: 18 January 2009
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study
Prasad Bichu, Ravi Nistala, Asma Khan, James R Sowers, Adam Whaley-Connell
Vascular Health and Risk Management 2009, 5:129-140
Published Date: 22 December 2008
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Odd Erik Johansen, Pål Johan Vanberg, Bente Kvarv Kilhovd, Anders Palmstrøm Jørgensen
Vascular Health and Risk Management 2009, 5:121-128
Published Date: 18 December 2008
Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization
Clarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, Bieito Campos, Dominick J Angiolillo, Manel Sabaté
Vascular Health and Risk Management 2009, 5:101-119
Published Date: 11 January 2009
Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial
Nader Nouri-Majalan, Reza Nafisi, Sarasadat Moghadasi-Mousavi
Vascular Health and Risk Management 2009, 5:97-100
Published Date: 10 December 2008
The independent relationship between triglycerides and coronary heart disease
Alan Morrison, John E Hokanson
Vascular Health and Risk Management 2009, 5:89-95
Published Date: 23 October 2008
Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women
Asha A Gader, Abed Elrahium D Haggaz, Ishag Adam
Vascular Health and Risk Management 2009, 5:85-87
Published Date: 4 December 2008
Differential expression of Gs in a murine model of homocysteinemic heart failure
Thomas P Vacek, Utpal Sen, Neetu Tyagi, Jonathan C Vacek, Munish Kumar, et al
Vascular Health and Risk Management 2009, 5:79-84
Published Date: 4 December 2008
Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors
Divina G Brillante, Anthony J O’Sullivan, Laurence G Howes
Vascular Health and Risk Management 2009, 5:73-78
Published Date: 4 December 2008
Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein
Miguel Arturo Salazar, Vázquez, Beatriz Yadira Salazar, Vázquez, M Intaglietta, Pedro Cabrales
Vascular Health and Risk Management 2009, 5:65-72
Published Date: 30 September 2008
Current management of type B aortic dissection
T Paul Tran, Ali Khoynezhad
Vascular Health and Risk Management 2009, 5:53-63
Published Date: 10 October 2008
Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples
Marjorie K Mau, Karynna Asao, Jimmy Efird, Erin Saito, Robert Ratner, et al
Vascular Health and Risk Management 2009, 5:45-52
Published Date: 7 December 2008
Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin
Jennifer G Robinson
Vascular Health and Risk Management 2009, 5:31-43
Published Date: 4 December 2008
Results of the ONTARGET and TRANSCEND studies: an update and discussion
David Fitchett
Vascular Health and Risk Management 2009, 5:21-29
Published Date: 4 December 2008
Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: How come?
Mahsa Mohammadi, Inger Ekman, Maria Schaufelberger
Vascular Health and Risk Management 2009, 5:13-19
Published Date: 2 December 2008
Alveolar dead space and capnographic variables before and after thrombolysis in patients with acute pulmonary embolism
Marcos Mello Moreira, Renato G G Terzi, Carlos Heitor N Carvalho, Antonio Francisco de Oliveira Neto, Mônica Corso Pereira, Ilma Aparecida Paschoal
Vascular Health and Risk Management 2009, 5:9-12
Published Date: 24 November 2008
Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes
Rajan Sharma, Denis Pellerin
Vascular Health and Risk Management 2009, 5:1-7
Published Date: 24 November 2008